Longevity, Performance & Obesity Capsules are a research formulation combining 5-Amino-1MQ, JBSNF-000088, and NMN: three small-molecule compounds studied for their roles in metabolic regulation, cellular energy balance, and longevity-associated pathways. This capsule-based formulation is designed strictly for controlled laboratory research focused on metabolic efficiency, performance signaling, and age-related metabolic decline models.
Prior to the development of these targeted compounds, metabolic and longevity research relied largely on indirect calorie restriction models or broad hormonal modulation. 5-Amino-1MQ has been studied for its role as a nicotinamide N-methyltransferase (NNMT) inhibitor, influencing energy expenditure and adiposity-related signaling. JBSNF-000088 has emerged in research settings for its potential involvement in metabolic regulation and obesity-associated pathways. NMN (nicotinamide mononucleotide) is a well-known NAD⁺ precursor studied for its role in mitochondrial function, cellular energy production, and aging-related processes. Together, these compounds allow researchers to explore complementary mechanisms involved in metabolic health and longevity.
Currently, Longevity, Performance & Obesity Capsules are being investigated for their potential role in studies involving metabolic health models, obesity-related signaling, insulin sensitivity pathways, mitochondrial efficiency, and age-associated performance decline. Additional research is exploring their influence on cellular energy utilization, lipid metabolism, and NAD⁺-dependent signaling pathways. As research continues, this formulation remains a compelling subject for advanced laboratory investigation into metabolic optimization and longevity mechanisms.
Longevity, Performance & Obesity Capsules are a capsule-format research formulation combining 5-Amino-1MQ, JBSNF-000088, and NMN. This blend is designed for laboratories exploring metabolic efficiency, energy regulation, and longevity-adjacent signaling within performance and body-composition research models.
In capsule form, this formulation is commonly incorporated into protocols where oral-delivery variables, compliance simulations, or longer-horizon exposure frameworks are required. Each lot is supported by documentation intended to align with research-grade sourcing standards and internal quality management workflows.
Longevity, Performance & Obesity Capsules – Research Specifications:
| Format | Capsules |
| Active Compounds | 5-Amino-1MQ, JBSNF-000088, NMN (research formulation blend) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific data |
| Source | Chemical synthesis / formulation |
| Appearance | Encapsulated powder |
| Storage Conditions | Store sealed in a cool, dry environment, protected from heat, light, and moisture. Maintain lot integrity per laboratory SOPs. |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption, clinical use, or veterinary applications. |
This formulation is engineered for researchers who want a single capsule-format variable that can support multi-endpoint study design. Instead of isolating one pathway, the blend allows investigators to interrogate coordinated signals that may intersect with energy balance, metabolic adaptation, and resilience-related biomarkers that show up across longevity and performance research.
5-Amino-1MQ Capsules is often discussed in metabolic research contexts where methylation-related and adiposity-adjacent pathways are under investigation. JBSNF-000088 is positioned as a research variable within broader metabolic efficiency and body-composition studies. NMN Capsules is commonly incorporated into studies that examine NAD+-adjacent metabolism and cellular energy systems, frequently benchmarked alongside related tools like NAD.
Teams designing obesity and performance research protocols often compare endpoints against adjacent weight-management references such as Advanced Fat Loss Stack and peptide-led category anchors like Retatrutide or Semaglutide depending on the experimental model and the evaluation framework.
Important Research Notice: Nordsci products are supported by lot-level analytical documentation. Certificates of Analysis are available to support internal audits, method alignment, and reproducibility across study phases.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Performance and obesity research often centers on energy regulation and substrate utilization. This formulation may be integrated into study designs where investigators track metabolic markers, energy expenditure proxies, and adaptation signals that respond to controlled variables such as diet composition and training-load analogs.
In body-composition models, researchers may analyze signals related to fat storage dynamics, lipolysis-adjacent pathways, and transcriptional responses to metabolic stressors. A blended capsule variable can support comparative analysis across cohorts when the objective is to quantify overlap between pathways rather than avoid it.
Longevity research frequently overlaps with performance outcomes because both categories depend on cellular energy systems and recovery capacity. Researchers may include this formulation when evaluating resilience-related biomarkers, mitochondrial signaling proxies, and NAD+-adjacent metabolism alongside broader longevity references such as Anti-Aging Longevity Stack or cellular performance variables like MOTS-C.
In more advanced experimental design, Longevity, Performance & Obesity Capsules may be positioned as a baseline capsule-format variable alongside category comparators such as Moderate Fat Loss Stack or peptide-specific endpoints derived from GLP-1-adjacent research frameworks. When running multi-variable stacks, define primary endpoints, sequencing, and confounder controls to keep attribution clean.
As a capsule-format research product, this formulation is commonly handled as a finished oral-input variable in laboratory workflows. Teams should document receiving, storage, and handling procedures in accordance with internal SOPs, study requirements, and applicable institutional controls.
Protocol Design Considerations: Metabolic research outcomes can be sensitive to baseline model status, feeding windows, activity/training analogs, sleep-cycle controls, and sampling cadence. Standardize these variables early and document them rigorously to protect data quality and reproducibility.
Note: The information above is provided as a high-level research reference only. All experimental use must be conducted by qualified personnel in appropriately equipped facilities, following applicable regulations and institutional policies.
Each lot of Longevity, Performance & Obesity Capsules is accompanied by a Certificate of Analysis documenting compound identity and quality parameters. COAs are intended to support protocol documentation, internal quality assurance, and reproducibility across research cohorts.
When sourcing capsule-format metabolic research formulations, laboratories should prioritize clear labeling, lot traceability, and documentation availability. Nordsci Peptides provides research-grade capsule products designed to integrate cleanly into compliance-focused procurement and study documentation workflows.
IMPORTANT: Longevity, Performance & Obesity Capsules are supplied exclusively for laboratory research use. Not approved for human consumption or therapeutic use. Researchers are responsible for compliance with all applicable laws, regulations, and institutional guidelines.
Browse Nordsci Products
Expandable categories. Full product glossary included for internal discovery and cross-navigation.
